• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

[Physician Comment] Favorable pregnancy outcomes, including low rate of pelvic adhesions, following robot-assisted laparoscopic myomectomy

bys25qthea
November 1, 2012
in Obstetrics, Surgery
Reading Time: 4 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: CC/Nimur

Study author, Dr. Antonio Gargiulo, talks to 2 Minute Medicine. Center for Infertility and Reproductive surgery and Medical Director of the Department of Robotic Surgery, Brigham and Women’s Hospital*:

“While the numbers alone from this study only demonstrate non-inferiority, the fact that the study population had higher-risk pregnancies suggests that these same women may have fared worse if they had instead undergone a laparoscopic or open (abdominal) fertility-preserving myomectomy.

Further, the finding that robotic myomectomy has a roughly one in ten chances of presenting with adhesions at cesarean delivery has important clinical implications for surgeons and patients alike. The finding has relevance because the rate of pelvic adhesions reported in the literature for abdomonal myomectomy range between 60% and 90% and for laparoscopic myomectomy between 25% and 33%. Pelvic adhesions at cesarean section are associated with higher risk of surgical complications. Because a very high number of women undergoing myomectomy are committed to a cesarean birth, this study has great clinical relevance and patients should be aware of these findings when choosing the type of myomectomy they undergo.”
*Other authors include Michael Pitter, Leo Bonaventura, J. Stefano Lehman and principal investigator Serene Srouji

Key study points:

1. In women undergoing fertility-preserving robot-assisted laparoscopic myomectomy (RALM), there was a low rate (11.4%) of pelvic adhesions.

RELATED REPORTS

Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

 2. Despite higher rates of pregnancy risk factors (infertility, obesity, advanced maternal age, and multiple pregnancy) in this cohort, pregnancy outcomes in women after RALM were similar to those published for patients after traditional laparoscopic myomectomy.

Primer: Robot-assisted laparoscopy is a technique that has been under development since the 1980s to address limitations of conventional laparoscopy (such as sub-optimal ergonomics and two-dimensional visualization) (1). The application of robot-assisted laparoscopic techniques to various surgical procedures, mainly employed today in urology and gynecology, has been debated in the academic community and the lay press, with skeptics questioning the cost-effectiveness of these procedures and calling attention to the paucity of research demonstrating definitive improvements in patient outcomes (2).

Fibroids are benign tumors of uterine smooth muscle that can cause heavy menstrual bleeding and adversely impact fertility. This typically occurs when submucosal fibroids distort the uterine cavity, impairing implantation, though some argue that intramural fibroids with intra-cavitary components may also adversely impact implantation. The treatments for fibroids are medical or surgical, with definitive treatment being a hysterectomy. The mainstay of therapy for women with bulk symptoms, abnormal uterine bleeding, and impaired fertility is surgical. For women desiring fertility and/or uterine preservation, a minimally-invasive myomectomy is the treatment of choice. Studies have shown that, as compared to abdominal and/or laparoscopic myomectomy, RALM for treatment of symptomatic fibroids is associated with decreased blood loss, less need for post-operative pain medication, decreased risk of pelvic adhesions, and shorter hospital stays (3, 5). However, RALMs come at greater cost (4). Short-term outcomes have been shown to be equivalent or better in patients undergoing RALM (5). The question remains, however, whether longer-term reproductive outcomes (namely, fertility and pregnancy outcomes) are significantly better in robot-assisted as compared to laparoscopic or abdominal myomectomies.

The present work is the first study to characterize long-term pregnancy outcomes, a marker for post-surgical uterine functionality, in women desiring fertility preservation who undergo RALM.

Background reading:

1.  Up-to-Date: Robot-Assisted Laparoscopy

2.  NY TImes OpEd by Ezekial Emanuel: “In Medicine, Falling for Fake Innovation”

3.  Surgical Outcomes in RALM vs Abd MMY

4.- Cost-effectiveness of abdominal, laparoscopic and robot-assisted myomectomy

5. Robot-assisted myomectomies: comparison of surgical outcomes and costs

This [retrospective cohort] study evaluated pregnancy outcomes from 872 women with fibroids who underwent RALM at three high-volume robotic surgery centers. The cohort consisted of women who desired minimally invasive fibroid treatment with uterine preservation. There were 127 pregnancies in the cohort after undergoing this procedure, over a five-year period.

Results showed that despite higher rates of infertility, obesity, advanced maternal age, and multiple pregnancy in this cohort of patients undergoing RALM, pregnancy outcomes were similar to those reported in the literature for patients after traditional laparoscopic myomectomy. The main pregnancy outcomes studied included rate of spontaneous abortions, ectopic pregnancies, and live births. One of the most striking findings of this study was the low rate of pelvic adhesions (11.4%) noted at the time of Cesarean delivery.

In sum: This study is the first to assess long-term pregnancy outcomes after RALM. Despite representing a higher-risk population, pregnancy outcomes in this cohort of women after RALM were similar to those previously published for patients after traditional laparoscopic myomectomy. 

Click to read the study in the current issue of Human Reproduction

By [LH] and [DB]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Primary anastomosis for perforated left colonic diverticulitis has a significantly higher rate of stoma reversal than Hartmann’s procedure

Next Post

Zoledronic acid therapy reduces risk of fracture in men with osteoporosis

RelatedReports

Collage of torn-gray map pieces with orange route from left to a doorway on the right, over a dark backdrop; scales of justice at top; '2 Minute Medicine' logo in bottom right.
Obstetrics

Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy

October 21, 2026
An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Artificial Intelligence

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

October 21, 2026
An artistic representation featuring a door with a key, symbolizing access or opportunity, alongside images of buildings and a heartbeat line, suggesting themes of health and housing.
Chronic Disease

A community health initiative in low-income areas may reduce hospital admission rates

October 20, 2026
Two pieces of fabric showing stitching techniques with surgical tools in the foreground, indicating procedures for hernia repair.
Gastroenterology

Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol

October 20, 2026
Next Post

Zoledronic acid therapy reduces risk of fracture in men with osteoporosis

Retired NFL players are at increased risk of death due to neurodegenerative disease

Terminal cancer patients hold misconceptions of the role of chemotherapy

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy
  • An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms
  • A community health initiative in low-income areas may reduce hospital admission rates
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.